Phase 3 Study of Ixazomib in Select Multiple Myeloma Patients Reports Benefits
Takeda Pharmaceutical Co. has announced that Ninlaro (ixazomib),…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Researchers Develop New Animal Model of Multiple Myeloma
Researchers in the Sylvester Comprehensive Cancer Center at the…
Potential Therapeutic Target for Drug-resistant Multiple Myelomas Identified in Study
A subunit of a signaling protein may be a new therapeutic target…
New Adjuvant Therapy Shows Promising Results to Treat Multiple Myeloma, B-Cell Malignancies
A new class of drugs that activate a protein…
Disrupting Specific Protein May Be Effective Multiple Myeloma Treatment Strategy
Researchers at Buffalo, New York-based Roswell Park Cancer Institute…
Protein Identified that May Point to Myeloma Patients Likely to Respond to Proteasome Inhibitors
Researchers at The University of Texas MD Anderson…
